Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXA4
|
ENSG00000197576.9 | homeobox A4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA4 | hg19_v2_chr7_-_27170352_27170418 | 0.01 | 9.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_92681033 | 12.28 |
ENST00000371697.3
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle) |
chr1_+_160160346 | 6.78 |
ENST00000368078.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
chr1_+_160160283 | 6.67 |
ENST00000368079.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
chr3_+_121311966 | 6.24 |
ENST00000338040.4
|
FBXO40
|
F-box protein 40 |
chr17_-_10452929 | 6.22 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
chr17_-_10421853 | 5.75 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
chr22_+_26138108 | 5.69 |
ENST00000536101.1
ENST00000335473.7 ENST00000407587.2 |
MYO18B
|
myosin XVIIIB |
chr1_-_100643765 | 5.50 |
ENST00000370137.1
ENST00000370138.1 ENST00000342895.3 |
LRRC39
|
leucine rich repeat containing 39 |
chr21_+_17442799 | 4.97 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr16_+_7382745 | 4.41 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr3_-_42744270 | 4.24 |
ENST00000457462.1
|
HHATL
|
hedgehog acyltransferase-like |
chr5_-_38557561 | 4.14 |
ENST00000511561.1
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr11_+_112046190 | 4.05 |
ENST00000357685.5
ENST00000393032.2 ENST00000361053.4 |
BCO2
|
beta-carotene oxygenase 2 |
chr10_-_75415825 | 4.02 |
ENST00000394810.2
|
SYNPO2L
|
synaptopodin 2-like |
chr4_-_152147579 | 4.00 |
ENST00000304527.4
ENST00000455740.1 ENST00000424281.1 ENST00000409598.4 |
SH3D19
|
SH3 domain containing 19 |
chr10_-_69455873 | 3.94 |
ENST00000433211.2
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3 |
chr3_-_42744130 | 3.87 |
ENST00000417472.1
ENST00000442469.1 |
HHATL
|
hedgehog acyltransferase-like |
chr3_-_52486841 | 3.75 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
chr11_+_12766583 | 3.66 |
ENST00000361985.2
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr11_+_27062860 | 3.64 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr11_-_13517565 | 3.53 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chr3_+_159557637 | 3.42 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr12_+_12938541 | 3.34 |
ENST00000356591.4
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr8_-_42358742 | 3.34 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr1_+_81771806 | 3.33 |
ENST00000370721.1
ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2
|
latrophilin 2 |
chr1_+_170632250 | 3.18 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
chr14_-_80697396 | 2.96 |
ENST00000557010.1
|
DIO2
|
deiodinase, iodothyronine, type II |
chr17_-_67138015 | 2.84 |
ENST00000284425.2
ENST00000590645.1 |
ABCA6
|
ATP-binding cassette, sub-family A (ABC1), member 6 |
chr8_+_79503458 | 2.72 |
ENST00000518467.1
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
chr16_+_6533380 | 2.72 |
ENST00000552089.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr1_+_214161272 | 2.72 |
ENST00000498508.2
ENST00000366958.4 |
PROX1
|
prospero homeobox 1 |
chr20_+_53092232 | 2.66 |
ENST00000395939.1
|
DOK5
|
docking protein 5 |
chr5_+_150406527 | 2.65 |
ENST00000520059.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr11_-_27494309 | 2.64 |
ENST00000389858.4
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4 |
chr5_-_1882858 | 2.61 |
ENST00000511126.1
ENST00000231357.2 |
IRX4
|
iroquois homeobox 4 |
chr11_-_27494279 | 2.58 |
ENST00000379214.4
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4 |
chr6_-_55740352 | 2.57 |
ENST00000370830.3
|
BMP5
|
bone morphogenetic protein 5 |
chr2_-_180427304 | 2.45 |
ENST00000336917.5
|
ZNF385B
|
zinc finger protein 385B |
chr15_+_51669444 | 2.35 |
ENST00000396399.2
|
GLDN
|
gliomedin |
chr9_+_87284622 | 2.35 |
ENST00000395882.1
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr1_-_216978709 | 2.27 |
ENST00000360012.3
|
ESRRG
|
estrogen-related receptor gamma |
chr20_+_53092123 | 2.26 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
chr21_+_17443521 | 2.24 |
ENST00000456342.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr12_-_86650045 | 2.23 |
ENST00000604798.1
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr2_-_69098566 | 2.19 |
ENST00000295379.1
|
BMP10
|
bone morphogenetic protein 10 |
chr7_-_14029283 | 2.13 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
chr10_-_33623310 | 2.13 |
ENST00000395995.1
ENST00000374823.5 ENST00000374821.5 ENST00000374816.3 |
NRP1
|
neuropilin 1 |
chr17_-_10372875 | 2.12 |
ENST00000255381.2
|
MYH4
|
myosin, heavy chain 4, skeletal muscle |
chr12_-_86650077 | 2.11 |
ENST00000552808.2
ENST00000547225.1 |
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr21_+_17961006 | 1.97 |
ENST00000602323.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chrX_-_55024967 | 1.96 |
ENST00000545676.1
|
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr9_+_87284675 | 1.92 |
ENST00000376208.1
ENST00000304053.6 ENST00000277120.3 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr12_-_86650154 | 1.91 |
ENST00000552435.2
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr2_-_190927447 | 1.85 |
ENST00000260950.4
|
MSTN
|
myostatin |
chr2_+_101437487 | 1.84 |
ENST00000427413.1
ENST00000542504.1 |
NPAS2
|
neuronal PAS domain protein 2 |
chr14_-_36988882 | 1.83 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr8_-_28347737 | 1.79 |
ENST00000517673.1
ENST00000518734.1 ENST00000346498.2 ENST00000380254.2 |
FBXO16
|
F-box protein 16 |
chr7_-_14028488 | 1.78 |
ENST00000405358.4
|
ETV1
|
ets variant 1 |
chr7_+_95115210 | 1.72 |
ENST00000428113.1
ENST00000325885.5 |
ASB4
|
ankyrin repeat and SOCS box containing 4 |
chrM_+_5824 | 1.72 |
ENST00000361624.2
|
MT-CO1
|
mitochondrially encoded cytochrome c oxidase I |
chr7_-_14026123 | 1.65 |
ENST00000420159.2
ENST00000399357.3 ENST00000403527.1 |
ETV1
|
ets variant 1 |
chr7_+_107110488 | 1.62 |
ENST00000304402.4
|
GPR22
|
G protein-coupled receptor 22 |
chr11_+_22688150 | 1.62 |
ENST00000454584.2
|
GAS2
|
growth arrest-specific 2 |
chr19_+_45409011 | 1.61 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr14_-_36989336 | 1.59 |
ENST00000522719.2
|
NKX2-1
|
NK2 homeobox 1 |
chr2_+_128403720 | 1.54 |
ENST00000272644.3
|
GPR17
|
G protein-coupled receptor 17 |
chr7_-_143892748 | 1.48 |
ENST00000378115.2
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr7_-_143991230 | 1.47 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr21_+_17443434 | 1.47 |
ENST00000400178.2
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr14_-_54423529 | 1.47 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
chr5_-_56778635 | 1.46 |
ENST00000423391.1
|
ACTBL2
|
actin, beta-like 2 |
chr20_+_57464200 | 1.45 |
ENST00000604005.1
|
GNAS
|
GNAS complex locus |
chr5_+_140810132 | 1.36 |
ENST00000252085.3
|
PCDHGA12
|
protocadherin gamma subfamily A, 12 |
chr12_-_11091862 | 1.36 |
ENST00000537503.1
|
TAS2R14
|
taste receptor, type 2, member 14 |
chr12_+_111537227 | 1.33 |
ENST00000397643.3
|
CUX2
|
cut-like homeobox 2 |
chr7_+_32996997 | 1.31 |
ENST00000242209.4
ENST00000538336.1 ENST00000538443.1 |
FKBP9
|
FK506 binding protein 9, 63 kDa |
chr2_-_105030466 | 1.30 |
ENST00000449772.1
|
AC068535.3
|
AC068535.3 |
chr16_-_85617170 | 1.29 |
ENST00000602862.1
|
RP11-118F19.1
|
RP11-118F19.1 |
chr3_-_120400960 | 1.24 |
ENST00000476082.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chr2_-_163099885 | 1.23 |
ENST00000443424.1
|
FAP
|
fibroblast activation protein, alpha |
chr10_-_62332357 | 1.16 |
ENST00000503366.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
chr2_-_163100045 | 1.15 |
ENST00000188790.4
|
FAP
|
fibroblast activation protein, alpha |
chr7_-_14026063 | 1.13 |
ENST00000443608.1
ENST00000438956.1 |
ETV1
|
ets variant 1 |
chr12_+_27677085 | 1.12 |
ENST00000545334.1
ENST00000540114.1 ENST00000537927.1 ENST00000318304.8 ENST00000535047.1 ENST00000542629.1 ENST00000228425.6 |
PPFIBP1
|
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
chr14_-_23395623 | 1.10 |
ENST00000556043.1
|
PRMT5
|
protein arginine methyltransferase 5 |
chr8_+_39792474 | 1.09 |
ENST00000502986.2
|
IDO2
|
indoleamine 2,3-dioxygenase 2 |
chrX_-_84634737 | 1.04 |
ENST00000262753.4
|
POF1B
|
premature ovarian failure, 1B |
chr8_+_77593474 | 1.04 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
chr12_-_16762971 | 1.02 |
ENST00000540590.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr2_+_128403439 | 1.02 |
ENST00000544369.1
|
GPR17
|
G protein-coupled receptor 17 |
chr5_+_159343688 | 0.96 |
ENST00000306675.3
|
ADRA1B
|
adrenoceptor alpha 1B |
chr17_-_77924627 | 0.96 |
ENST00000572862.1
ENST00000573782.1 ENST00000574427.1 ENST00000570373.1 ENST00000340848.7 ENST00000576768.1 |
TBC1D16
|
TBC1 domain family, member 16 |
chr4_+_66536248 | 0.94 |
ENST00000514260.1
ENST00000507117.1 |
RP11-807H7.1
|
RP11-807H7.1 |
chr10_-_105845536 | 0.94 |
ENST00000393211.3
|
COL17A1
|
collagen, type XVII, alpha 1 |
chr12_-_57037284 | 0.90 |
ENST00000551570.1
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
chr15_+_36994210 | 0.89 |
ENST00000562489.1
|
C15orf41
|
chromosome 15 open reading frame 41 |
chr4_+_84457250 | 0.89 |
ENST00000395226.2
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr15_+_51669513 | 0.88 |
ENST00000558426.1
|
GLDN
|
gliomedin |
chr11_-_40315640 | 0.84 |
ENST00000278198.2
|
LRRC4C
|
leucine rich repeat containing 4C |
chr8_-_10512569 | 0.83 |
ENST00000382483.3
|
RP1L1
|
retinitis pigmentosa 1-like 1 |
chr9_-_113341985 | 0.83 |
ENST00000374469.1
|
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr4_+_84457529 | 0.81 |
ENST00000264409.4
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr17_-_10325261 | 0.80 |
ENST00000403437.2
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal |
chr12_-_24103841 | 0.79 |
ENST00000541847.1
|
SOX5
|
SRY (sex determining region Y)-box 5 |
chr2_-_171571077 | 0.79 |
ENST00000409786.1
|
AC007405.2
|
long intergenic non-protein coding RNA 1124 |
chr10_-_101825151 | 0.78 |
ENST00000441382.1
|
CPN1
|
carboxypeptidase N, polypeptide 1 |
chr3_+_2553281 | 0.74 |
ENST00000434053.1
|
CNTN4
|
contactin 4 |
chr5_+_152870106 | 0.74 |
ENST00000285900.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr3_-_64253655 | 0.74 |
ENST00000498162.1
|
PRICKLE2
|
prickle homolog 2 (Drosophila) |
chr9_-_113342160 | 0.74 |
ENST00000401783.2
ENST00000374461.1 |
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr21_+_17909594 | 0.70 |
ENST00000441820.1
ENST00000602280.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr6_+_31514622 | 0.69 |
ENST00000376146.4
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
chr7_-_140714430 | 0.68 |
ENST00000393008.3
|
MRPS33
|
mitochondrial ribosomal protein S33 |
chr8_-_141774467 | 0.67 |
ENST00000520151.1
ENST00000519024.1 ENST00000519465.1 |
PTK2
|
protein tyrosine kinase 2 |
chr1_-_12677714 | 0.66 |
ENST00000376223.2
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3 |
chr3_-_129513259 | 0.66 |
ENST00000329333.5
|
TMCC1
|
transmembrane and coiled-coil domain family 1 |
chr5_+_40909354 | 0.66 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr8_+_22424551 | 0.64 |
ENST00000523348.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr8_+_77593448 | 0.64 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr3_+_122103014 | 0.63 |
ENST00000232125.5
ENST00000477892.1 ENST00000469967.1 |
FAM162A
|
family with sequence similarity 162, member A |
chr12_+_72058130 | 0.62 |
ENST00000547843.1
|
THAP2
|
THAP domain containing, apoptosis associated protein 2 |
chr9_-_16253112 | 0.62 |
ENST00000380683.1
|
C9orf92
|
chromosome 9 open reading frame 92 |
chr5_+_133562095 | 0.61 |
ENST00000602919.1
|
CTD-2410N18.3
|
CTD-2410N18.3 |
chr9_-_16276311 | 0.61 |
ENST00000380685.1
|
C9orf92
|
chromosome 9 open reading frame 92 |
chr10_-_105845674 | 0.60 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr2_-_163099546 | 0.59 |
ENST00000447386.1
|
FAP
|
fibroblast activation protein, alpha |
chr14_+_37131058 | 0.59 |
ENST00000361487.6
|
PAX9
|
paired box 9 |
chr15_+_89631647 | 0.54 |
ENST00000569550.1
ENST00000565066.1 ENST00000565973.1 |
ABHD2
|
abhydrolase domain containing 2 |
chr19_-_10047219 | 0.49 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
chr8_-_99955042 | 0.49 |
ENST00000519420.1
|
STK3
|
serine/threonine kinase 3 |
chr12_+_53848549 | 0.47 |
ENST00000439930.3
ENST00000548933.1 ENST00000562264.1 |
PCBP2
|
poly(rC) binding protein 2 |
chr5_+_60933634 | 0.44 |
ENST00000505642.1
|
C5orf64
|
chromosome 5 open reading frame 64 |
chr11_+_112832133 | 0.44 |
ENST00000524665.1
|
NCAM1
|
neural cell adhesion molecule 1 |
chr6_-_31514516 | 0.43 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr1_+_167298281 | 0.42 |
ENST00000367862.5
|
POU2F1
|
POU class 2 homeobox 1 |
chr6_+_152011628 | 0.42 |
ENST00000404742.1
ENST00000440973.1 |
ESR1
|
estrogen receptor 1 |
chr1_+_155658849 | 0.41 |
ENST00000368336.5
ENST00000343043.3 ENST00000421487.2 ENST00000535183.1 ENST00000465375.1 ENST00000470830.1 |
DAP3
|
death associated protein 3 |
chr15_-_61945400 | 0.40 |
ENST00000560686.1
|
RP11-507B12.1
|
RP11-507B12.1 |
chr15_+_89631381 | 0.38 |
ENST00000352732.5
|
ABHD2
|
abhydrolase domain containing 2 |
chr1_+_245318279 | 0.37 |
ENST00000407071.2
|
KIF26B
|
kinesin family member 26B |
chr2_+_87135076 | 0.35 |
ENST00000409776.2
|
RGPD1
|
RANBP2-like and GRIP domain containing 1 |
chr11_+_120971882 | 0.33 |
ENST00000392793.1
|
TECTA
|
tectorin alpha |
chr5_+_66300446 | 0.32 |
ENST00000261569.7
|
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr5_+_66254698 | 0.32 |
ENST00000405643.1
ENST00000407621.1 ENST00000432426.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr5_+_69321074 | 0.31 |
ENST00000380751.5
ENST00000380750.3 ENST00000503931.1 ENST00000506542.1 |
SERF1B
|
small EDRK-rich factor 1B (centromeric) |
chr5_+_67586465 | 0.30 |
ENST00000336483.5
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr7_+_129015671 | 0.28 |
ENST00000466993.1
|
AHCYL2
|
adenosylhomocysteinase-like 2 |
chr18_+_13612613 | 0.28 |
ENST00000586765.1
|
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr2_-_187367356 | 0.27 |
ENST00000595956.1
|
AC018867.2
|
AC018867.2 |
chr1_-_204329013 | 0.26 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
chr14_+_101359265 | 0.26 |
ENST00000599197.1
|
AL117190.3
|
Esophagus cancer-related gene-2 interaction susceptibility protein; Uncharacterized protein |
chr14_+_39734482 | 0.25 |
ENST00000554392.1
ENST00000555716.1 ENST00000341749.3 ENST00000557038.1 |
CTAGE5
|
CTAGE family, member 5 |
chr3_-_178984759 | 0.24 |
ENST00000349697.2
ENST00000497599.1 |
KCNMB3
|
potassium large conductance calcium-activated channel, subfamily M beta member 3 |
chr11_-_5080857 | 0.24 |
ENST00000321522.2
|
OR52E2
|
olfactory receptor, family 52, subfamily E, member 2 |
chr17_+_37894570 | 0.23 |
ENST00000394211.3
|
GRB7
|
growth factor receptor-bound protein 7 |
chr2_+_53994927 | 0.23 |
ENST00000295304.4
|
CHAC2
|
ChaC, cation transport regulator homolog 2 (E. coli) |
chr7_+_100273736 | 0.23 |
ENST00000412215.1
ENST00000393924.1 |
GNB2
|
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
chr18_-_28742813 | 0.23 |
ENST00000257197.3
ENST00000257198.5 |
DSC1
|
desmocollin 1 |
chr9_+_26746951 | 0.23 |
ENST00000523363.1
|
RP11-18A15.1
|
RP11-18A15.1 |
chr5_+_140535577 | 0.22 |
ENST00000539533.1
|
PCDHB17
|
Protocadherin-psi1; Uncharacterized protein |
chr9_+_75263565 | 0.21 |
ENST00000396237.3
|
TMC1
|
transmembrane channel-like 1 |
chr16_+_67280799 | 0.21 |
ENST00000566345.2
|
SLC9A5
|
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
chr3_+_9774164 | 0.21 |
ENST00000426583.1
|
BRPF1
|
bromodomain and PHD finger containing, 1 |
chr10_-_101690650 | 0.19 |
ENST00000543621.1
|
DNMBP
|
dynamin binding protein |
chrX_-_84634708 | 0.18 |
ENST00000373145.3
|
POF1B
|
premature ovarian failure, 1B |
chr2_+_54683419 | 0.17 |
ENST00000356805.4
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
chr12_-_10959892 | 0.17 |
ENST00000240615.2
|
TAS2R8
|
taste receptor, type 2, member 8 |
chr3_-_188665428 | 0.17 |
ENST00000444488.1
|
TPRG1-AS1
|
TPRG1 antisense RNA 1 |
chr7_+_8474817 | 0.16 |
ENST00000429542.1
|
NXPH1
|
neurexophilin 1 |
chrX_+_129473859 | 0.16 |
ENST00000424447.1
|
SLC25A14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
chr7_+_144052381 | 0.13 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chr21_+_22370717 | 0.13 |
ENST00000284894.7
|
NCAM2
|
neural cell adhesion molecule 2 |
chr13_-_28545276 | 0.11 |
ENST00000381020.7
|
CDX2
|
caudal type homeobox 2 |
chr12_+_53818855 | 0.11 |
ENST00000550839.1
|
AMHR2
|
anti-Mullerian hormone receptor, type II |
chr12_-_24097236 | 0.10 |
ENST00000538083.1
|
SOX5
|
SRY (sex determining region Y)-box 5 |
chr3_+_108855558 | 0.10 |
ENST00000467240.1
ENST00000477643.1 ENST00000479039.1 ENST00000593799.1 |
RP11-59E19.1
|
RP11-59E19.1 |
chr5_-_13944652 | 0.10 |
ENST00000265104.4
|
DNAH5
|
dynein, axonemal, heavy chain 5 |
chr15_+_80351977 | 0.09 |
ENST00000559157.1
ENST00000561012.1 ENST00000564367.1 ENST00000558494.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
chr18_-_658244 | 0.08 |
ENST00000585033.1
ENST00000323813.3 |
C18orf56
|
chromosome 18 open reading frame 56 |
chr8_-_95449155 | 0.08 |
ENST00000481490.2
|
FSBP
|
fibrinogen silencer binding protein |
chr7_-_27170352 | 0.08 |
ENST00000428284.2
ENST00000360046.5 |
HOXA4
|
homeobox A4 |
chr5_+_152870287 | 0.07 |
ENST00000340592.5
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr19_-_893200 | 0.07 |
ENST00000269814.4
ENST00000395808.3 ENST00000312090.6 ENST00000325464.1 |
MED16
|
mediator complex subunit 16 |
chr15_-_33447055 | 0.05 |
ENST00000559047.1
ENST00000561249.1 |
FMN1
|
formin 1 |
chr1_-_159832438 | 0.04 |
ENST00000368100.1
|
VSIG8
|
V-set and immunoglobulin domain containing 8 |
chr7_-_130598059 | 0.04 |
ENST00000432045.2
|
MIR29B1
|
microRNA 29a |
chr5_+_152870215 | 0.02 |
ENST00000518142.1
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1 |
chr2_+_171571827 | 0.02 |
ENST00000375281.3
|
SP5
|
Sp5 transcription factor |
chr12_-_120241187 | 0.00 |
ENST00000392520.2
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 8.1 | GO:0060262 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
1.4 | 4.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
1.3 | 5.2 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
1.2 | 3.5 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
1.0 | 13.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
1.0 | 3.0 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.9 | 3.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.9 | 2.7 | GO:0043049 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.7 | 4.3 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.6 | 4.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 1.7 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.5 | 2.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.5 | 1.6 | GO:2000646 | lipid transport involved in lipid storage(GO:0010877) positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 1.8 | GO:1902725 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
0.4 | 12.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 2.1 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.4 | 6.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 2.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 3.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.5 | GO:0072200 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.3 | 3.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.3 | 2.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 3.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.3 | 6.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 3.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 1.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 4.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 4.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 4.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 1.2 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.2 | 3.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 3.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 3.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 1.4 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 0.8 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 2.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 2.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 1.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 7.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 1.8 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 1.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 3.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 1.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.7 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 2.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 3.6 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 1.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 2.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 2.7 | GO:0009798 | axis specification(GO:0009798) |
0.0 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 1.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 2.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 1.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 6.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 5.6 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 5.2 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 13.5 | GO:0014802 | terminal cisterna(GO:0014802) |
0.8 | 6.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 3.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.6 | 3.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.5 | 1.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 8.7 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 5.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 2.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 3.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 3.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 19.7 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 4.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 1.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 1.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 7.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 1.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.0 | 4.1 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.9 | 3.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.7 | 4.3 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.7 | 6.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 2.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 3.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 3.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 3.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 3.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 2.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 2.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.2 | 3.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 3.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 2.2 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.2 | 9.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 2.7 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.2 | 3.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 2.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 5.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 3.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.9 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 3.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 2.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 3.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.8 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 1.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 5.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 11.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 2.6 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 1.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 1.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 2.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 8.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 2.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 6.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 2.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 6.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 6.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 4.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 2.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 5.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 17.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 4.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 1.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 4.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 2.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 3.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 4.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 3.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |